Skip to main content
AAN.com
Brief Communications
August 30, 2006

POLG1 in idiopathic Parkinson disease

November 14, 2006 issue
67 (9) 1698-1700

Abstract

We studied POLG1 in 140 UK patients with idiopathic Parkinson disease (PD) and 279 Italian patients with PD and compared them to a UK control group (n = 207) and an Italian control group (n = 285). Our observations do not support a role for common POLG1 genetic variants in PD and indicate that dominant POLG1 mutations are a rare cause of parkinsonism in the general population.

Get full access to this article

View all available purchase options and get full access to this article.

Supplementary Material

File (e1.doc)
File (e2.doc)

References

1.
Naviaux RK, Nguyen KV. POLG mutations associated with Alpers’ syndrome and mitochondrial DNA depletion. Ann Neurol 2004;55:706–712.
2.
Van Goethem G, Martin JJ, Dermaut B, et al. Recessive POLG mutations presenting with sensory and ataxic neuropathy in compound heterozygote patients with progressive external ophthalmoplegia. Neuromuscul Disord 2003;13:133–142.
3.
Luoma P, Melberg A, Rinne JO, et al. Parkinsonism, premature menopause, and mitochondrial DNA polymerase gamma mutations: clinical and molecular genetic study. Lancet 2004;364:875–882.
4.
Mancuso M, Filosto M, Oh SJ, DiMauro S. A novel polymerase gamma mutation in a family with ophthalmoplegia, neuropathy, and parkinsonism. Arch Neurol 2004;61:1777–1179.
5.
Chan SS, Longley MJ, Copeland WC. The common A467T mutation in the human mitochondrial DNA polymerase (POLG) compromises catalytic efficiency and interaction with the accessory subunit. J Biol Chem 2005;280:31341–31346.
6.
Chan SS, Longley MJ, Naviaux RK, Copeland WC. Mono-allelic POLG expression resulting from nonsense-mediated decay and alternative splicing in a patient with Alpers syndrome. DNA Repair (Amst) 2005;4:1381–1389.
7.
Rovio AT, Marchington D, Donat S, et al. Mutations at the mitochondrial DNA polymerase (POLG) locus associated with male infertility. Nat Genet 2001;29:261–262.
8.
Ghezzi D, Marelli C, Achilli A, et al. Mitochondrial DNA haplogroup K is associated with a lower risk of Parkinson’s disease in Italians. Eur J Hum Genet 2005;13:748–752.
9.
Lamantea E, Tiranti V, Bordoni A, et al. Mutations of mitochondrial DNA polymerase gammaA are a frequent cause of autosomal dominant or recessive progressive external ophthalmoplegia. Ann Neurol 2002;52:211–219.
10.
Davidzon G, Greene P, Mancuso M, et al. Early-onset familial parkinsonism due to POLG mutations. Ann Neurol 2006;59:859–862.

Information & Authors

Information

Published In

Neurology®
Volume 67Number 9November 14, 2006
Pages: 1698-1700
PubMed: 16943369

Publication History

Published online: August 30, 2006
Published in print: November 14, 2006

Permissions

Request permissions for this article.

Authors

Affiliations & Disclosures

W. Tiangyou, MSc
From the Department of Neurology (W.T., G.H., D.J.B., P.F.C.) and Institute of Human Genetics (P.F.C.), The University of Newcastle upon Tyne, UK; Unit of Molecular Neurogenetics (D.G., G.F., M.Z.), Pierfranco and Luisa Mariani Center for the Study of Children’s Mitochondrial Disorders, National Neurological Institute, Milan, Italy; and Department of Neurology (D.J.B., P.F.C.), Regional Neurosciences Centre, Newcastle General Hospital, Newcastle upon Tyne, UK.
G. Hudson, PhD
From the Department of Neurology (W.T., G.H., D.J.B., P.F.C.) and Institute of Human Genetics (P.F.C.), The University of Newcastle upon Tyne, UK; Unit of Molecular Neurogenetics (D.G., G.F., M.Z.), Pierfranco and Luisa Mariani Center for the Study of Children’s Mitochondrial Disorders, National Neurological Institute, Milan, Italy; and Department of Neurology (D.J.B., P.F.C.), Regional Neurosciences Centre, Newcastle General Hospital, Newcastle upon Tyne, UK.
D. Ghezzi, PhD
From the Department of Neurology (W.T., G.H., D.J.B., P.F.C.) and Institute of Human Genetics (P.F.C.), The University of Newcastle upon Tyne, UK; Unit of Molecular Neurogenetics (D.G., G.F., M.Z.), Pierfranco and Luisa Mariani Center for the Study of Children’s Mitochondrial Disorders, National Neurological Institute, Milan, Italy; and Department of Neurology (D.J.B., P.F.C.), Regional Neurosciences Centre, Newcastle General Hospital, Newcastle upon Tyne, UK.
G. Ferrari, PhD
From the Department of Neurology (W.T., G.H., D.J.B., P.F.C.) and Institute of Human Genetics (P.F.C.), The University of Newcastle upon Tyne, UK; Unit of Molecular Neurogenetics (D.G., G.F., M.Z.), Pierfranco and Luisa Mariani Center for the Study of Children’s Mitochondrial Disorders, National Neurological Institute, Milan, Italy; and Department of Neurology (D.J.B., P.F.C.), Regional Neurosciences Centre, Newcastle General Hospital, Newcastle upon Tyne, UK.
M. Zeviani, MD, PhD
From the Department of Neurology (W.T., G.H., D.J.B., P.F.C.) and Institute of Human Genetics (P.F.C.), The University of Newcastle upon Tyne, UK; Unit of Molecular Neurogenetics (D.G., G.F., M.Z.), Pierfranco and Luisa Mariani Center for the Study of Children’s Mitochondrial Disorders, National Neurological Institute, Milan, Italy; and Department of Neurology (D.J.B., P.F.C.), Regional Neurosciences Centre, Newcastle General Hospital, Newcastle upon Tyne, UK.
D. J. Burn, FRCP
From the Department of Neurology (W.T., G.H., D.J.B., P.F.C.) and Institute of Human Genetics (P.F.C.), The University of Newcastle upon Tyne, UK; Unit of Molecular Neurogenetics (D.G., G.F., M.Z.), Pierfranco and Luisa Mariani Center for the Study of Children’s Mitochondrial Disorders, National Neurological Institute, Milan, Italy; and Department of Neurology (D.J.B., P.F.C.), Regional Neurosciences Centre, Newcastle General Hospital, Newcastle upon Tyne, UK.
P. F. Chinnery, PhD, FRCP
From the Department of Neurology (W.T., G.H., D.J.B., P.F.C.) and Institute of Human Genetics (P.F.C.), The University of Newcastle upon Tyne, UK; Unit of Molecular Neurogenetics (D.G., G.F., M.Z.), Pierfranco and Luisa Mariani Center for the Study of Children’s Mitochondrial Disorders, National Neurological Institute, Milan, Italy; and Department of Neurology (D.J.B., P.F.C.), Regional Neurosciences Centre, Newcastle General Hospital, Newcastle upon Tyne, UK.

Notes

Address correspondence and reprint requests to Dr. Patrick F. Chinnery, M41014, The Medical School, Framlington Place, Newcastle upon Tyne, NE2 4HH UK; e-mail: [email protected]

Metrics & Citations

Metrics

Citation information is sourced from Crossref Cited-by service.

Citations

Download Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.

Cited By
  1. The Y831C Mutation of the POLG Gene in Dementia, Biomedicines, 11, 4, (1172), (2023).https://doi.org/10.3390/biomedicines11041172
    Crossref
  2. Insights into the promising prospect of pharmacological approaches targeting mitochondrial dysfunction in major human diseases: At a glance, Process Biochemistry, 132, (41-74), (2023).https://doi.org/10.1016/j.procbio.2023.07.007
    Crossref
  3. Parkinson’s Disease, Parkinsonisms, and Mitochondria: the Role of Nuclear and Mitochondrial DNA, Current Neurology and Neuroscience Reports, 23, 4, (131-147), (2023).https://doi.org/10.1007/s11910-023-01260-8
    Crossref
  4. Mitochondrial DNA homeostasis impairment and dopaminergic dysfunction: A trembling balance, Ageing Research Reviews, 76, (101578), (2022).https://doi.org/10.1016/j.arr.2022.101578
    Crossref
  5. Targeting Mitochondria as a Therapeutic Approach for Parkinson’s Disease, Cellular and Molecular Neurobiology, 43, 4, (1499-1518), (2022).https://doi.org/10.1007/s10571-022-01265-w
    Crossref
  6. Insights into Lewy body disease from rare neurometabolic disorders, Journal of Neural Transmission, 128, 10, (1567-1575), (2021).https://doi.org/10.1007/s00702-021-02355-7
    Crossref
  7. Nuclear Genes Associated with Mitochondrial DNA Processes as Contributors to Parkinson's Disease Risk , Movement Disorders, 36, 4, (815-831), (2021).https://doi.org/10.1002/mds.28475
    Crossref
  8. Role of Genes and Treatments for Parkinson’s Disease, The Open Biology Journal, 8, 1, (47-65), (2020).https://doi.org/10.2174/1874196702008010047
    Crossref
  9. The Role of Mitochondria in Neurodegenerative Diseases: the Lesson from Alzheimer’s Disease and Parkinson’s Disease, Molecular Neurobiology, 57, 7, (2959-2980), (2020).https://doi.org/10.1007/s12035-020-01926-1
    Crossref
  10. Role of the mitochondrial DNA replication machinery in mitochondrial DNA mutagenesis, aging and age-related diseases, Ageing Research Reviews, 33, (89-104), (2017).https://doi.org/10.1016/j.arr.2016.04.006
    Crossref
  11. See more
Loading...

View Options

Login options

Check if you have access through your login credentials or your institution to get full access on this article.

Personal login Institutional Login
Purchase Options

The neurology.org payment platform is currently offline. Our technical team is working as quickly as possible to restore service.

If you need immediate support or to place an order, please call or email customer service:

  • 1-800-638-3030 for U.S. customers - 8:30 - 7 pm ET (M-F)
  • 1-301-223-2300 for customers outside the U.S. - 8:30 - 7 pm ET (M-F)
  • [email protected]

We appreciate your patience during this time and apologize for any inconvenience.

View options

PDF and All Supplements

Download PDF and Supplementary Material

Full Text

View Full Text

Full Text HTML

View Full Text HTML

Figures

Tables

Media

Share

Share

Share article link

Share